NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Hindware Home Innovation Q3 Results: Turnaround to ₹3.69 Cr Profit; Revenue Up 7.7% YoY
Hindware Home Innovation reported a consolidated net profit of ₹3.69 crore for Q3 FY26, marking a significant recovery from a net loss of ₹16.94 crore in the previous year's corresponding quarter. Revenue from operations grew by 7.7% YoY to ₹640.08 crore, supported by steady growth in the Building Products segment. The company is actively streamlining operations by exiting high-loss consumer categories like air coolers and fans to focus on core kitchen appliances. A major corporate restructuring involving a demerger and amalgamation is currently awaiting NCLT approval.
முக்கிய அம்சங்கள்
Consolidated revenue rose 7.7% YoY to ₹640.08 crore in Q3 FY26 compared to ₹594.23 crore in Q3 FY25.Reported a net profit of ₹3.69 crore, turning around from a net loss of ₹16.94 crore in the year-ago period.EBITDA grew significantly to ₹51.57 crore from ₹37.49 crore in the same period last year.Building Products segment revenue increased to ₹558.71 crore from ₹526.88 crore YoY.Exceptional items include a ₹4.65 crore impact from new labor codes and adjustments for discontinued product categories.
👀 கவனிக்க வேண்டியவை
The return to profitability and strategic exit from loss-making segments are encouraging signs for long-term margin improvement. Investors should monitor the progress of the NCLT-led corporate restructuring scheme which aims to simplify the business structure.
Amara Raja Q3 FY26: 9M Revenue Hits INR 1 Lakh Cr; New 5 GWh BESS Giga Factory Announced
Amara Raja Energy & Mobility (ARE&M) reported a standalone revenue of INR 1,00,889 million for 9M FY26 with an EBITDA margin of 11.6%. The company is accelerating its transition to New Energy, announcing a 5 GWh Battery Energy Storage System (BESS) Giga Factory with a capex of INR 280 crores. The lithium pack business for telecom reached a significant milestone of INR 200 crores in quarterly revenue, while the traditional 4W OEM lead-acid segment maintained double-digit growth. Strategic investments continue with a INR 200 crore infusion into its subsidiary ARACT for advanced cell manufacturing.
முக்கிய அம்சங்கள்
9M FY26 Standalone Revenue reached INR 1,00,889 Mn with EBITDA of INR 11,671 Mn.Announced 5 GWh BESS Giga Factory with INR 280 Cr capex, targeting operations by FY28.New Energy telecom packs crossed INR 200 Cr revenue milestone with 80%+ capacity utilization.Infused INR 200 Cr into subsidiary ARACT; 16 GWh Giga-cell plant construction is underway.Lead recycling refinery operations commenced in Dec 2024, with battery breaking expected in Q4 FY26.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's successful scale-up of the lithium pack business and the progress of the Giga-cell factory as it pivots toward energy transition. The core lead-acid business remains a stable cash generator, supporting the aggressive INR 95 billion long-term capex plan.
Amara Raja to Incorporate US Subsidiary with $5 Million Investment for Global Expansion
Amara Raja Energy & Mobility (ARE&M) has approved the incorporation of a wholly owned subsidiary in the USA, tentatively named 'ARE&M US Inc.' The company plans to invest up to USD 5 million in this new entity through equity, loans, or capital expenditure in one or more tranches. This move is aimed at strengthening customer service capabilities, facilitating global business expansion, and establishing a local presence to evaluate future manufacturing or assembly opportunities in the US market. The incorporation process is expected to be completed within the next 3 to 6 months.
முக்கிய அம்சங்கள்
Board approved a 100% wholly owned subsidiary in the USA to be incorporated within 3-6 months.Total investment commitment of up to USD 5 million in equity, loans, or other securities.Primary focus on battery and components distribution and improving customer service response times.Strategic intent to evaluate future localization, including potential manufacturing or assembly in the US.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward global diversification and potential entry into the US energy storage market. Monitor future updates regarding localization plans or larger capital commitments in the US.
Aarey Drugs & Pharmaceuticals Limited held a board meeting on February 11, 2026, to approve the unaudited financial results for the quarter ended December 31, 2025. The board confirmed the submission of the Limited Review Report and MD/CFO certifications as per SEBI regulations. The company operates in a single business segment, focusing on bulk drugs and chemical imports. While the specific profit and loss figures were not detailed in this cover letter, the results have been officially taken on record.
முக்கிய அம்சங்கள்
Board approved unaudited financial results for the quarter ended December 31, 2025.The board meeting was held on February 11, 2026, from 3:00 p.m. to 6:30 p.m.MD and CFO provided formal certification regarding the accuracy of the financial statements.The company confirmed it operates within a single reporting segment.
👀 கவனிக்க வேண்டியவை
Investors should look for the detailed financial tables on the stock exchange to evaluate revenue growth and margin performance. Monitor the company's ability to manage raw material costs in the bulk drug and solvent import business.
Amara Raja Q3 Revenue Up 6% YoY to ₹3,351 Cr; New Energy Segment Crosses ₹200 Cr Milestone
Amara Raja Energy & Mobility reported a 6% year-on-year revenue growth to ₹3,350.84 crore for Q3 FY26, supported by strong domestic automotive OEM demand. However, profitability faced significant pressure as Profit Before Tax (PBT) fell to ₹207.48 crore from ₹422.16 crore in the previous year's corresponding quarter. The New Energy business achieved a key milestone by crossing ₹200 crore in revenue, while exports were hampered by geopolitical tensions. The company remains on track for its Gigafactory commercial production by early next calendar year.
முக்கிய அம்சங்கள்
Revenue from operations increased 6% YoY to ₹3,350.84 crore in Q3 FY26.Profit before tax (PBT) declined sharply to ₹207.48 crore compared to ₹422.16 crore in Q3 FY25.New Energy Business revenue crossed the ₹200 crore mark for the first time in a quarter.Exports saw a decline during the period due to ongoing global geopolitical tensions.Gigafactory commercial production remains on track for early next calendar year (2027).
👀 கவனிக்க வேண்டியவை
Investors should monitor the impact of geopolitical headwinds on export margins and the significant decline in PBT. While the New Energy segment's growth is a positive long-term catalyst, the current bottom-line volatility suggests a cautious approach until margins stabilize.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
CARE Ratings Reports Strong Q3 FY26 Performance with 24% YoY Growth in Consolidated PAT
CARE Ratings Limited reported a robust performance for 9M FY26, with consolidated revenue from operations growing 17% YoY to Rs. 342.40 crore. Profitability saw a significant jump as consolidated PAT rose 24% YoY to Rs. 120.25 crore, driven by operational efficiencies and a 46% standalone EBITDA margin. While the ratings segment remains the core contributor at 89% of revenue, the non-ratings segment showed faster growth at 21% YoY. Despite a 11% decline in corporate bond issuances during Q3, the company benefited from a 14.5% increase in bank credit offtake.
முக்கிய அம்சங்கள்
Consolidated PAT for 9M FY26 grew by 24% YoY to Rs. 120.25 crore with a 32% margin.Consolidated revenue from operations for 9M FY26 increased 17% YoY to Rs. 342.40 crore.Standalone EBITDA margin stood at a healthy 46% for 9M FY26, up from 44% in the previous year.Non-ratings segment revenue grew by 21% YoY to Rs. 36.71 crore, contributing 11% to total revenue.Bank credit offtake accelerated to 14.5% growth as of December 2025, supporting rating volumes.
👀 கவனிக்க வேண்டியவை
Investors should view the strong margin expansion and growth in non-rating segments as positive indicators of business diversification and efficiency. The stock remains a play on the Indian credit cycle and private capex revival, though moderation in bond issuances is a factor to watch.
Amara Raja Q3 FY26 Consolidated Net Profit Drops 53% YoY to ₹140.15 Crore
Amara Raja Energy & Mobility reported a modest 4.2% YoY growth in consolidated revenue to ₹3,410.15 crore for the quarter ended December 31, 2025. However, consolidated net profit saw a sharp decline of 53% YoY to ₹140.15 crore, significantly impacted by rising raw material costs and an exceptional charge of ₹47.63 crore related to new labour code gratuity liabilities. The company continues its capital-intensive transition toward green energy, infusing an additional ₹200 crore into its advanced cell technology subsidiary during the quarter.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations increased 4.2% YoY to ₹3,410.15 crore.Consolidated Net Profit fell 53% YoY to ₹140.15 crore from ₹298.37 crore in the previous year.Exceptional item of ₹47.63 crore recognized due to increased gratuity liability from the new Labour Codes.Cost of materials consumed rose approximately 10% YoY to ₹2,247.13 crore, impacting operating margins.Total investment in Amara Raja Advanced Cell Technologies reached ₹1,400.01 crore following a ₹200 crore infusion this quarter.
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin pressure resulting from rising input costs and the heavy capital expenditure required for the new energy business. While the core battery business remains stable, the short-term profitability is likely to remain volatile during the transition to advanced cell manufacturing.
CARE Ratings Q3 Net Profit Jumps 29% YoY to ₹35.9 Crore; Revenue Up 16%
CARE Ratings reported a strong year-on-year performance for the quarter ended December 31, 2025, with consolidated net profit rising 29.1% to ₹35.9 crore. Revenue from operations grew by 16.3% YoY to ₹112.1 crore, reflecting steady demand in the credit rating and analytics business. While sequential performance showed a decline from the September quarter, the nine-month (9M FY26) net profit remains robust at ₹118.3 crore, a 25% increase over the previous year. The company continues to manage its cost base effectively despite a rise in employee benefit expenses.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations increased 16.3% YoY to ₹112.12 crore in Q3 FY26.Net Profit attributable to owners grew 29.1% YoY to ₹35.90 crore from ₹27.80 crore.9M FY26 Net Profit reached ₹118.34 crore, up 25% compared to ₹94.63 crore in 9M FY25.Total expenses for the quarter rose to ₹76.12 crore, with employee costs accounting for ₹55.13 crore.Other income remained a significant contributor at ₹12.99 crore for the quarter.
👀 கவனிக்க வேண்டியவை
Investors should view the strong year-on-year growth as a positive indicator of the company's market position. The stock remains a key beneficiary of the expanding Indian corporate bond market and credit growth.
Saregama India Limited reported operating revenue of INR 260 crores for Q3 FY26, with the core music segment growing 29% year-on-year. The company reported an operating PBT of INR 76.5 crores, though a one-time non-cash charge of INR 7 crores for the new Labour Code reduced reported PBT to INR 69.5 crores. Management finalized a strategic minority investment in Bhansali Productions on January 30, 2026, securing exclusive access to marquee film music at pre-agreed costs. The company is pivoting away from in-house film production to focus on short-format video, artist management, and live events.
முக்கிய அம்சங்கள்
Music segment revenue grew 29% YoY in Q3, with 9-month growth reaching 18% despite the Airtel Wynk exit impact.Finalized strategic minority investment in Bhansali Productions, ensuring future access to high-profile Hindi film music.New content spend for FY26 projected at INR 275-300 crores, slightly lower than planned due to release delays of major titles.Artist management vertical now handles 270+ artists with a combined social media following of over 300 million.Maintained long-term guidance of 21-23% music revenue growth and 32-33% adjusted EBITDA margins.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's transition toward a more capital-efficient model by winding down in-house films and leveraging the Bhansali partnership. The stock remains a strong play on the increasing monetization of music streaming through paid subscriptions in India.
Saregama India CFO Pankaj Chaturvedi Resigns Effective March 31, 2026
Saregama India Limited has announced the resignation of Mr. Pankaj Chaturvedi from the position of Chief Financial Officer (CFO) and Key Managerial Personnel. The resignation was submitted on February 10, 2026, and will take effect from the close of business hours on March 31, 2026. The company cited personal reasons for his departure and confirmed there are no other material reasons. This transition period gives the company approximately seven weeks to identify and appoint a successor.
முக்கிய அம்சங்கள்
Mr. Pankaj Chaturvedi resigned as CFO and Key Managerial Personnel on February 10, 2026.The resignation is scheduled to be effective from the close of business hours on March 31, 2026.Departure is attributed to personal reasons with no other material concerns cited by the outgoing CFO.The company has a transition window of nearly 50 days to manage the leadership change.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's upcoming announcements regarding the appointment of a new CFO to ensure continuity in financial management. The planned transition period suggests an orderly exit, but the choice of successor will be key for maintaining market confidence.
India Ratings Places Waaree Renewable's INR 258M Bank Facilities on Rating Watch
India Ratings and Research (Ind-Ra) has placed Waaree Renewable Technologies Limited's bank loan facilities worth INR 258 million on 'Rating Watch with Developing Implications'. The facilities, primarily involving the Indian Renewable Energy Development Agency Limited (IREDA), currently hold an 'IND A' rating. This 'Watch' status indicates that the rating could change based on upcoming developments or further information. Investors should note that while the current rating is investment grade, the developing implications suggest a period of uncertainty regarding the credit profile.
முக்கிய அம்சங்கள்
Bank loan facilities totaling INR 258.00 million placed on Rating Watch with Developing Implications.The current credit rating assigned by India Ratings is 'IND A'.The primary lender for the rated facilities is the Indian Renewable Energy Development Agency Limited (IREDA).The rating action was officially communicated to the company on February 05, 2026.The 'Developing Implications' status suggests potential for rating movement based on future events or data.
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming detailed credit rating rationale to understand the specific factors causing the 'Developing Implications' status. Maintain a neutral stance until the rating agency provides a final outlook or rating resolution.
Share India to Hold NCLT-Convened Meeting on March 13 for Silverleaf Capital Amalgamation
Share India Securities has scheduled NCLT-convened meetings on March 13, 2026, to seek approval for the amalgamation of Silverleaf Capital Services Private Limited into the company. The meetings will be held via video conferencing for equity shareholders, NCD holders, and creditors. The cut-off date to determine voting eligibility for shareholders and NCD holders is March 6, 2026. This move follows the initial merger disclosure made in September 2025 and represents a significant step in the company's corporate restructuring.
முக்கிய அம்சங்கள்
NCLT-convened meetings scheduled for March 13, 2026, starting at 12:00 PM for equity shareholders.Remote e-voting period is set from March 9, 2026 (9:00 AM) to March 12, 2026 (5:00 PM).Cut-off date for determining voting rights for shareholders and NCD holders is March 6, 2026.The merger involves the transferor company Silverleaf Capital Services Private Limited.Separate meetings are mandated for Secured Creditors (3:30 PM) and Unsecured Creditors (4:30 PM).
👀 கவனிக்க வேண்டியவை
Investors should review the scheme of amalgamation details in the provided notice links to assess the impact on share value. Eligible shareholders should participate in the e-voting process between March 9 and March 12 to exercise their rights.
Waaree Energies Subsidiary Secures 150MW Solar Module Order from International IPP
Waaree Energies' US-based subsidiary, Waaree Solar Americas Inc., has bagged a contract to supply 150MW of solar modules to a major international Independent Power Producer. The supply is scheduled to take place across the years 2026 and 2027, providing healthy revenue visibility for the next two fiscal years. This order strengthens the company's international footprint and market share in the competitive US solar market. The transaction is between non-related parties and was conducted at arm's length.
முக்கிய அம்சங்கள்
Receipt of a 150MW solar module supply order from a renowned international IPPOrder secured through wholly owned subsidiary Waaree Solar Americas Inc.Supply timeline spans across the calendar years 2026 and 2027The contract is a one-time international order with no promoter interest involved
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for the company's export order book and US market penetration. Monitor the execution timeline and its impact on upcoming quarterly revenue realizations.
Hindware Home Innovation Announces NCLT-Directed Meeting for Composite Scheme of Arrangement
Hindware Home Innovation Limited is progressing with a Composite Scheme of Arrangement involving its subsidiaries HHIL Limited and Hindware Limited. As per NCLT Kolkata Bench directions, a meeting of unsecured creditors of Hindware Limited is scheduled for March 7, 2026, to approve the restructuring. The company has already secured no-objection letters from BSE and NSE in August 2025. The cut-off date for determining the entitlement of voting rights for creditors was fixed as September 30, 2025.
முக்கிய அம்சங்கள்
Meeting of unsecured creditors of Hindware Limited scheduled for March 7, 2026, in Kolkata.Cut-off date for determining voting rights of unsecured creditors set as September 30, 2025.Scheme involves demerger and merger between Hindware Home Innovation, HHIL Ltd, and Hindware Ltd.No-objection letters received from BSE and NSE on August 28 and 29, 2025, respectively.Restructuring is being conducted under Sections 230 to 232 of the Companies Act, 2013.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the creditors' meeting and subsequent NCLT approvals to understand the final corporate structure. Evaluate how the demerger of specific business units might impact the listed entity's valuation.
Religare Enterprises Clarifies on Care Health Insurance Demerger and Listing Rumors
Religare Enterprises Limited has issued a clarification to the stock exchanges regarding a media report suggesting a potential demerger and listing of Care Health Insurance. The company stated that there is currently no pending information or event that requires disclosure under SEBI (LODR) Regulations. While management acknowledges they evaluate strategic growth opportunities on an ongoing basis, they confirmed that the news item has no material impact at this stage. This response effectively denies any immediate or finalized plans for the rumored demerger.
முக்கிய அம்சங்கள்
Exchange sought clarification on a Moneycontrol article dated February 03, 2026, regarding Care Health Insurance.Company confirms no event currently exists that requires disclosure under SEBI Regulation 30.Religare states there is no material impact on the company resulting from the news article.Management maintains they evaluate strategic opportunities for growth and expansion on an ongoing basis.The response was filed on February 03, 2026, in response to surveillance queries from BSE and NSE.
👀 கவனிக்க வேண்டியவை
Investors should treat the demerger news as speculative until an official board-approved announcement is made. Monitor the stock for price volatility as the market reacts to the company's denial of immediate plans.
Saregama Q3 FY26 PAT Rises 17% to Rs 512 Mn; Music Licensing Revenue Up 23% QoQ
Saregama reported a robust Q3 FY26 with revenue from operations reaching Rs 2,604 Mn, a 13% sequential growth. Net profit (PAT) increased by 17% to Rs 512 Mn, even after accounting for a Rs 70 Mn non-cash exceptional charge related to labour code implementation. The company made a significant strategic move by acquiring a minority stake in Bhansali Productions, securing exclusive access to marquee Hindi film music. The core Music Licensing and Artiste Management segment remains the primary growth engine, recording a 29% year-on-year revenue increase.
முக்கிய அம்சங்கள்
Revenue from operations stood at Rs 2,604 Mn, recording a 13% QoQ growth.Music Licensing and Artiste Management revenue grew by 23% QoQ and 29% YoY.Operational PBT (excluding exceptional items) grew 27% to Rs 765 Mn.Strategic investment in Bhansali Productions provides exclusive music IP access at predictable costs.Digital footprint reached 550 Mn+ followers with YouTube views hitting 278 Bn in Q3.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's aggressive IP acquisition strategy and the high-margin growth in music licensing. The strategic partnership with Sanjay Leela Bhansali acts as a significant moat for future content pipeline.
Saregama Q3 FY26 Revenue up 13% QoQ to Rs 2,604 Mn; Music Licensing grows 29% YoY
Saregama reported a robust Q3 FY26 with revenue reaching Rs 2,604 Mn, driven by a 23% QoQ surge in its core Music Licensing and Artiste Management segment. Operational PBT grew by 27% to Rs 765 Mn, although reported PAT growth was 17% at Rs 512 Mn due to a one-time Rs 70 Mn non-cash charge for labour code implementation. A strategic minority investment in Bhansali Productions was a key highlight, securing exclusive access to marquee Hindi film music. The company continues to scale its digital footprint, now reaching 550 million followers across social platforms.
முக்கிய அம்சங்கள்
Revenue from operations stood at Rs 2,604 Mn, marking a 13% QoQ growth.Music Licensing and Artiste Management revenue grew 23% QoQ and 29% YoY to Rs 2,038 Mn.Adjusted EBITDA reached Rs 1,210 Mn, while PAT grew 17% YoY to Rs 512 Mn.Strategic minority investment in Bhansali Productions ensures exclusive access to future music IPs.Digital reach expanded to 550 million subscribers with 278 billion YouTube views in the quarter.
👀 கவனிக்க வேண்டியவை
Investors should focus on the strong growth in high-margin licensing revenue and the strategic value of the Bhansali partnership. The company's successful diversification into live events and influencer management provides a healthy long-term growth runway.
Thyrocare Q3 FY26: Revenue Grows 18% YoY; Pathology Up 20% with Record 10,300 Franchisees
Thyrocare reported a strong Q3 FY26 with consolidated revenue growing 18% YoY, led by a 20% surge in the pathology segment. The company processed 49.6 million tests, a 22% increase, and expanded its active franchisee base to a record 10,300 partners. While the core franchisee business grew 12%, the partnership and insurance segments saw robust growth of 39% and 70% respectively. Management also highlighted achieving Six Sigma quality standards and the appointment of new leadership to drive further expansion.
முக்கிய அம்சங்கள்
Consolidated revenue grew 18% YoY, with the core pathology business increasing by 20%.Total tests processed rose 22% YoY to 49.6 million, serving 4.5 million patients (up 14% YoY).Active quarterly franchisee base reached an all-time high of 10,300, up from 9,165 in the previous year.Partnership business revenue jumped 39% YoY, while the pre-policy medical checkup segment grew 70%.Achieved Six Sigma quality benchmark with 3.2 complaints per million tests, a 43% YoY improvement.
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of the partnership business and the path to breakeven for the Tanzania operations. The strong volume growth and record franchisee additions indicate robust market share gains and operational efficiency.
Saregama Completes INR 325 Crore Investment in Bhansali Productions
Saregama India Limited has officially completed the acquisition of securities in Bhansali Productions Private Limited (BPPL). The company has subscribed to 9,960 Compulsory Convertible Preference Shares (CCPS) for a total consideration of INR 325 Crores. This strategic investment, finalized on January 30, 2026, aligns with Saregama's focus on high-quality content and intellectual property. The deal strengthens the company's relationship with one of India's premier film production houses led by Sanjay Leela Bhansali.
முக்கிய அம்சங்கள்
Acquisition of 9,960 Compulsory Convertible Preference Shares (CCPS) completed.Total investment consideration stands at INR 325 Crores.The CCPS carry a face value of Rs 10 each with a 0.0001% dividend rate.Strategic partnership with Sanjay Leela Bhansali's production house to boost content IP.Transaction concluded following the initial investment agreement dated December 16, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor the synergy between Saregama's music business and BPPL's film projects, as this could lead to significant IP monetization. The stock remains a long-term play on the Indian media and entertainment sector's growth.
Share India Q3 FY26: Standalone PAT up 35% YoY; ADTO jumps 29% to ₹9,700 Cr
Share India Securities reported a steady Q3 FY26 with consolidated PAT growing 8% YoY to ₹89 crore, while standalone PAT surged 35% to ₹81 crore. The company saw significant operational growth with Average Daily Turnover (ADTO) increasing 29% QoQ to ₹9,700 crore, driven by commodity market volatility. Management is diversifying into wealth management, PMS, and debt markets, with several new subsidiaries expected to be operational by Q1 FY27. A third interim dividend of ₹0.40 per share was also declared.
முக்கிய அம்சங்கள்
Standalone revenue grew 18% YoY to ₹305 crore, with standalone PAT increasing 35% to ₹81 croreConsolidated ADTO rose by 29% QoQ to ₹9,700 crore, supported by increased interest in commoditiesInstitutional client base expanded by 13% QoQ to 174 active institutionsDeclared a third interim dividend of ₹0.40 per share (20% on face value of ₹2)MTF book grew 3% QoQ to ₹457 crore despite high market volatility in small and mid-cap segments
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the new wealth management and AIF verticals launching in FY27, which could diversify revenue streams beyond traditional broking. The strong growth in ADTO and institutional empanelment suggests increasing market share and operational efficiency.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
